NanoNewron, Inc.
PrivateLast Round
Grant
Sep 10, 2025
Total Funding Raised
$3M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
NanoNewron, Inc. is a biotechnology company that develops humanized biologics designed to cross the blood-brain barrier to treat central nervous system diseases such as Alzheimer's.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NanoNewron, Inc. Comparables
Compare NanoNewron, Inc. with similar companies based on industry and business-model similarity.
NanoNewron, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 10, 2025 | ||||
| Grant | Feb 15, 2023 |
Key People
Founding team and executive leadership
NanoNewron, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Aging | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 1150% MoM, reaching 1.8K.
- Sep 10, 2025
$3M grant awarded by the National Institutes of Health.
NanoNewron, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NanoNewron, Inc.'s valuation, stock price, and market status.